SMSLIFEPharmaceuticals
SMS Lifesciences India Ltd — PE Ratio & Valuation Analysis
₹1258.80
+0.00%
Current P/E22.54xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E20.1x12.0% above avg
✅
29.1% Discount to Industry
SMSLIFE P/E 22.54x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹66.51 | ₹1324 | 19.9x |
| 2024 | ₹30.08 | ₹1176 | 39.1x |
| 2023 | ₹37.92 | ₹530 | 14x |
| 2022 | ₹83.76 | ₹626 | 7.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding SMS Lifesciences India Ltd Valuation
SMS Lifesciences India Ltd (SMSLIFE) currently trades at 22.54x earnings. The Pharmaceuticals sector average PE is 31.77x. SMSLIFE is trading at a discount to peers — may indicate relative value. Historically, SMSLIFE has traded at an average PE of 20.1x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
10.76%
Dividend Yield
0.11%
More on SMS Lifesciences India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.